Shelter Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹45 crore and net profit of ₹5.21 crore for the September 2026 quarter.
Shelter Pharma (BSE: SHELTER) closed at ₹45.80 on 20 Nov 2026, up 8.0% over the past year. Its market capitalisation is ₹77 crore and it trades at 7.9 times earnings.
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including food supplements for animals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.